A Retrospective, Non-interventional Study to Evaluate the Use of Seroquel XR and Seroquel IR in the Clinical Practice of Outpatients With Schizophrenia.
Phase of Trial: Phase IV
Latest Information Update: 07 Mar 2011
At a glance
- Drugs Quetiapine (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 07 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Feb 2011 Planned end date changed from 1 Dec 2010 to 1 Feb 2011 as reported by ClinicalTrials.gov.
- 09 Nov 2010 Actual initiation date (Oct 2010) added as reported by ClinicalTrials.gov.